Genentech follows current CDC guidelines and recommends that you are fully vaccinated to attend a live in person Speaker Program. We suggest you plan on attending a virtual program if you are not fully vaccinated.
Join us in person or online to learn more about Evrysdi.
We are pleased to offer in-person and online educational events. These events give you the opportunity to learn about Evrysdi from experts and hear directly from people currently taking Evrysdi. To find and register for an in-person event in your area, please enter your ZIP code or choose your local PAL representative name below. To register for online events, follow the "Register" links from the list below.
Please enter your ZIP code or local PAL
(Search results will show In-Person Events within a 100-mile radius and all Virtual Events by date.)
Wednesday, August 3, 6:00 PM PDT
Shade Moody, MD
UT Health Science Center-Houston
Amanda Bradhurst, BSN, CDE, RN
Northern Californa & Central California
Avanzando Un Vistazo Mas de Cerca a Evrysdi
Tuesday, August 9, 6:00 PM PDT
This event is currently not open for registration. Please search for another event.
Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
are pregnant or plan to become pregnant. If you are pregnant, or are planning to become pregnant, ask your healthcare provider for advice before taking this medicine. Evrysdi may harm your unborn baby.
are a woman who can become pregnant:
Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy. Because Evrysdi may harm your unborn baby, your healthcare provider will decide if taking Evrysdi is right for you during this time
Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
are an adult male planning to have children: Evrysdi may affect a man’s ability to have children (fertility). If this is of concern to you, make sure to ask a healthcare provider for advice
are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby. If you plan to breastfeed, discuss with your healthcare provider about the best way to feed your baby while on treatment with Evrysdi
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine
You should receive Evrysdi from the pharmacy as a liquid that can be given by mouth or through a feeding tube. The liquid solution is prepared by your pharmacist. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
The most common side effects of Evrysdi include:
For later-onset SMA:
For infantile-onset SMA:
runny nose, sneezing, sore throat, and cough (upper respiratory infection)
These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.
You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.